Sanofi Earnings Emphasize Need For Medivation Buy
This article was originally published in The Pink Sheet Daily
Executive Summary
Medivation rejects the bid during the French pharma's earnings call, claiming the "opportunistically-timed proposal" took advantage of the drop in the biotech market.